Related Experiment Video
Updated: Feb 15, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
Proteomic Profile of Lymphoid Leukemia
1Department of Applied Medical Sciences, Community College, Unaizah, Qassim University, Qassim, Saudi Arabia.
Lymphoid (or lymphocytic/lymphoblastic) leukemia, one of two major types of leukemias (lymphoid and myeloid), is divided into two subtypes, acute lymphoid leukemia (ALL) and chronic lymphocytic leukemia (CLL), depending on the maturation stage and speed of multiplication of the bone marrow lymphocytes. Early diagnosis and treatment can make the difference between life and death. Advancements in the field of proteomics may allow the development of early biomarkers and more effective agents to combat both these types of cancer, and to better understand the underlying mechanisms of the disease. The aim of this review was to elucidate the pathophysiology of lymphocytic leukemia using cancer proteomics techniques from 2007 until 2017. Only relevant original research articles archived in the Science Direct, PubMed and/or the Google Scholar databases within this period were included, which were a total of 30 studies. The role of proteomes in the detection, diagnosis and treatment of ALL and CLL was examined separately. Overall, the findings of this study confirm the viability of proteome analysis in profiling lymphocytic leukemia; and highlight novel leukemia biomarkers and potential therapeutic targets.
Lymphoid (or lymphocytic/lymphoblastic) leukemia, one of two major types of leukemias (lymphoid and myeloid), is divided into two subtypes, acute lymphoid leukemia (ALL) and chronic lymphocytic leukemia (CLL), depending on the maturation stage and speed of multiplication of the bone marrow lymphocytes. Early diagnosis and treatment can make the difference between life and death. Advancements in the field of proteomics may allow the development of early biomarkers and more effective agents to combat both these types of cancer, and to better understand the underlying mechanisms of the disease. The aim of this review was to elucidate the pathophysiology of lymphocytic leukemia using cancer proteomics techniques from 2007 until 2017. Only relevant original research articles archived in the Science Direct, PubMed and/or the Google Scholar databases within this period were included, which were a total of 30 studies. The role of proteomes in the detection, diagnosis and treatment of ALL and CLL was examined separately. Overall, the findings of this study confirm the viability of proteome analysis in profiling lymphocytic leukemia; and highlight novel leukemia biomarkers and potential therapeutic targets.
Related Concept Videos
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Taping Over Different Ground Profiles

